Senseonics, Inc.
Clinical trials sponsored by Senseonics, Inc., explained in plain language.
Develops continuous glucose monitoring systems for diabetes management.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
-
New glucose monitor aims for better accuracy and safety in diabetes care
Disease control Recruiting nowThis study is testing a new continuous glucose monitoring system called ROME GS in 60 adults with type 1 or type 2 diabetes. The goal is to see if it measures blood sugar accurately and is safe to use. Participants will wear the sensor and have their glucose levels checked agains…
Sponsor: Senseonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
New flash glucose monitor aims to make diabetes management easier and safer
Disease control Recruiting nowThis study is testing a new glucose monitoring system called Eversense Gemini, which includes a flash glucose measurement feature. The goal is to see how accurate and safe it is for adults with type 1 or type 2 diabetes. About 80 participants will wear the device and have their g…
Sponsor: Senseonics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC